GlassScriptPhysician profile
Christopher M Sherman
NPI 1851616635
$12,592.39
in general payments reported to CMS, 2019-2025
55 companies · $1,802 in 2025
The $1,802 reported for 2025 was more than what 78% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,700 · 2020: $688 · 2021: $885 · 2022: $2,997 · 2023: $2,876 · 2024: $1,644 · 2025: $1,802.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,287 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,287.33 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $3,433.91 | 2020-2024 | Axonics, Bulkamid |
| Pfizer INC. | $714.45 | 2019-2025 | |
| Janssen Biotech, INC. | $696.16 | 2019-2025 | Erleada, Rybrevant, Carvykti |
| Dendreon Pharmaceuticals LLC | $625.17 | 2019-2025 | Provenge |
| Astellas Pharma US INC | $587.28 | 2019-2025 | Xtandi, Myrbetriq |
| Sumitomo Pharma America, INC. | $552.65 | 2023-2025 | Orgovyx, Gemtesa |
| Myriad Genetic Laboratories, INC. | $514.98 | 2022-2024 | Prolaris |
| Boston Scientific Corporation | $453.33 | 2019-2025 | Axonics, Spaceoar Vue System - 10ml |
| Abbvie INC. | $423.24 | 2019-2025 | Botox, Lupron Depot |
| Merck Sharp & Dohme LLC | $308.65 | 2022-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Amgen INC. | $306.16 | 2019-2022 | |
| Coloplast Corp | $255.31 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $243.82 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $241.36 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $235.32 | 2022-2025 | Imfinzi, Lynparza |
Show all 54 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $232.75 | 2020-2024 | Xiaflex, Aveed, Edex |
| Urogen Pharma, INC. | $229.90 | 2022-2025 | Jelmyto |
| Ferring Pharmaceuticals INC. | $202.34 | 2019-2025 | Adstiladrin |
| Teleflex LLC | $192.12 | 2022-2025 | Urolift |
| Procept Biorobotics Corporation | $182.74 | 2023-2025 | Aquabeam Robotic System, Aquabeam System |
| Accord Healthcare, INC. | $142.98 | 2023-2025 | |
| Progenics Pharmaceuticals, INC. | $142.41 | 2022-2024 | Pylarify |
| Avadel Specialty Pharmaceuticals, LLC | $117.51 | 2019 | |
| Janssen Scientific Affairs, LLC | $110.44 | 2019 | |
| Tolmar, INC. | $101.85 | 2023-2024 | |
| Sn Holdings, LLC | $96.66 | 2022 | |
| Laborie Medical Technologies Corp. | $96.17 | 2022-2025 | Endosheath Technology |
| Tolmar Pharmaceuticals, INC. | $91.44 | 2019-2022 | |
| Telix Pharmaceuticals | $86.40 | 2023-2025 | Illuccix |
| Myovant Sciences INC. | $80.26 | 2021-2022 | |
| Blue Earth Diagnostics | $79.71 | 2019-2024 | |
| Immunitybio, INC. | $65.70 | 2025 | |
| Urovant Sciences INC | $62.91 | 2022 | |
| Endo USA, INC. | $61.36 | 2024-2025 | Aveed, Xiaflex |
| Zyla Life Sciences, INC. | $59.45 | 2019-2020 | |
| Clarus Therapeutics INC. | $54.44 | 2021 | |
| Calyxo, INC. | $54.26 | 2024-2025 | Cvac Aspiration System |
| Sun Pharmaceutical Industries INC. | $53.24 | 2019-2024 | |
| Rochester Medical Corporation | $51.59 | 2019-2020 | |
| 180 Medical, INC. | $50.21 | 2019-2020 | |
| Allergan, INC. | $47.50 | 2019-2021 | |
| Bluewind Medical | $36.06 | 2024 | Revi |
| Medtronic USA, INC. | $29.71 | 2019-2020 | |
| C. R. Bard, INC. & Subsidiaries | $28.34 | 2019 | |
| Foundation Medicine, INC. | $26.51 | 2023 | |
| Azurity Pharmaceuticals, INC. | $20.12 | 2025 | Azmiro |
| Medtronic, INC. | $20.03 | 2022 | |
| Dentsply Ih INC. | $18.77 | 2020 | |
| Olympus America INC. | $15.77 | 2023 | Itind System |
| Shionogi INC | $14.30 | 2021 | |
| Medivation Field Solutions LLC | $13.91 | 2019 | |
| Neotract INC. | $12.77 | 2020 | |
| Ambu INC. | $10.48 | 2022 | |
| Edap Technomed INC | $7.49 | 2025 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$66,817.72 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Sherman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.